Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2019
Price : $35 *
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Acronyms VITAL-DKD
- 31 Aug 2018 Biomarkers information updated
- 13 May 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.
- 26 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.